Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

RespireRx Pharmaceuticals Inc.

http://www.respirerx.com

Latest From RespireRx Pharmaceuticals Inc.

EU Firsts Beckon For Olumiant In Dermatitis & Orfadin For AKU

The European Medicine Agency has recommended extending the therapeutic indication of a raft of drugs that are already authorized in the EU.

Europe Drug Review

CryoLife Adds To Aortic Repair Line With Ascyrus Acquisition

The Ascyrus Medical Dissection Stent is designed to help remodel the aortic arch following an aortic dissection. CryoLife will pay up to $200m for Ascyrus.

M & A Cardiovascular

Asia Deal Watch: Takeda Will Employ Engitix’s ECM Tech In Liver Fibrosis Indications

Takeda’s collaboration with the private UK biotech includes NASH and other liver disorders. Reliance will take on Amazon in the India pharmacy space with acquisition of Netmeds.

Deals Business Strategies

Amazon Pharmacy Starting Up In India: What Pharma Could Gain Or Lose

Amazon Pharmacy’s debut in India could recalibrate and disrupt drug dispensing and distribution in the country, while also tempering investment flow in the e-pharmacy segment. Some experts also predict a squeeze on pharma’s profits.

India Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Cortex Pharmaceuticals, Inc.
    • Pier Pharmaceuticals, Inc.
UsernamePublicRestriction

Register